BioSyent (CVE:RX) Sets New 12-Month High Following Dividend Announcement

BioSyent Inc. (CVE:RX)’s stock price hit a new 52-week high on Friday following a dividend announcement from the company. The stock traded as high as C$12.40 and last traded at C$12.10, with a volume of 15454 shares trading hands. The stock had previously closed at C$11.59.

The newly announced dividend which will be paid on Monday, September 15th. Investors of record on Friday, August 29th will be given a $0.05 dividend. This represents a $0.20 dividend on an annualized basis and a dividend yield of 1.7%. BioSyent’s dividend payout ratio is currently 29.21%.

BioSyent Stock Performance

The company has a debt-to-equity ratio of 2.90, a quick ratio of 6.91 and a current ratio of 3.92. The stock’s 50-day moving average is C$11.58 and its 200 day moving average is C$11.24. The firm has a market cap of C$137.36 million, a P/E ratio of 19.49 and a beta of 0.93.

About BioSyent

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.